Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 9994-10001
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.9994
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.9994
Survival | Tumour-related survival | |||
5-yr rate | P value | 5-yr rate | P value | |
Stage I | 0.812 | 0.674 | ||
Fibrinogen ≤ 400 mg/dL | 91.5 | 98.3 | ||
Fibrinogen > 400 mg/dL | 88.2 | 95.2 | ||
Stage II | 0.036 | 0.467 | ||
Fibrinogen ≤ 400 mg/dL | 81.7 | 92.2 | ||
Fibrinogen > 400 mg/dL | 74.0 | 92.1 | ||
Stage III | 0.206 | 0.627 | ||
Fibrinogen ≤ 400 mg/dL | 70.6 | 81.8 | ||
Fibrinogen > 400 mg/dL | 60.8 | 85.0 | ||
Stage IV | 0.566 | 0.213 | ||
Fibrinogen ≤ 400 mg/dL | 30.0 | 31.8 | ||
Fibrinogen > 400 mg/dL | 40.4 | 61.2 |
- Citation: Pedrazzani C, Mantovani G, Salvagno GL, Baldiotti E, Ruzzenente A, Iacono C, Lippi G, Guglielmi A. Elevated fibrinogen plasma level is not an independent predictor of poor prognosis in a large cohort of Western patients undergoing surgery for colorectal cancer. World J Gastroenterol 2016; 22(45): 9994-10001
- URL: https://www.wjgnet.com/1007-9327/full/v22/i45/9994.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i45.9994